Stem Cell Research · 2016 · 13 citations · 4 references
Life SciencesNeurosciencePsychiatryMolecular NeurobiologyMolecular NeuroscienceStem Cell BiologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyNeural Stem CellsPluripotent Stem CellsTreatment-resistant Psychiatric DisordersInduced Pluripotent Stem Cell ModelsInduced Pluripotent Stem Cell ReprogrammingInduced Pluripotent Stem CellsPluripotencyPluripotency InductionPluripotent Stem Cell DifferentiationReprogrammingSchizophrenia Genetics
Peripheral Blood Mononuclear Cells (PBMCs) were collected from a patient with clozapine-resistant (also known as "super-refractory") Schizophrenia. iPSCs were established with a non-integrating Sendai virus-based reprogramming system. A footprint-free hiPSC line was characterized to express the main endogenous pluripotency markers and to retain a normal karyotype. Cells showed pluripotency competency by giving rise to progeny of differentiated cells belonging to the three germ layers. This hiPSC line represents a valuable tool to obtain mature, pathology-relevant neuronal populations in vitro that are suitable to investigate the molecular background of the schizophrenic disorder and the resultant patients' response to treatments.
4
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki et al. · Cell · 2007 · 20.2K citations
Noemi Fusaki, Hiroshi Ban, Akiyo Nishiyama et al. · Proceedings of the Japan Academy Series B · 2009 · 1.4K citations · Full text
Treatment-refractory schizophrenia
Asaf Caspi, Michael Davidson, Carol A. Tamminga · Dialogues in Clinical Neuroscience · 2004 · 37 citations · Full text
Medicine, Pharmacology, Psychiatry +17
Treatment-refractory schizophrenia.
Asaf Caspi, Michael Davidson, Carol A. Tamminga · PubMed · 2004 · 29 citations